Go to:
Logótipo
Comuta visibilidade da coluna esquerda
Você está em: Start > Publications > View > Methylphenidate effects in the young brain: friend or foe?
Publication

Publications

Methylphenidate effects in the young brain: friend or foe?

Title
Methylphenidate effects in the young brain: friend or foe?
Type
Another Publication in an International Scientific Journal
Year
2017
Authors
Loureiro Vieira, S
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Costa, VM
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Maria de Lourdes Bastos
(Author)
FFUP
View Personal Page You do not have permissions to view the institutional email. Search for Participant Publications View Authenticus page View ORCID page
Felix Carvalho
(Author)
FFUP
View Personal Page You do not have permissions to view the institutional email. Search for Participant Publications View Authenticus page Without ORCID
Capela, JP
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Journal
Vol. 60
Pages: 34-47
ISSN: 0736-5748
Publisher: Wiley-Blackwell
Other information
Authenticus ID: P-00M-REP
Abstract (EN): Attention deficit hyperactivity disorder (ADHD) is one of the most prevalent neuropsychiatry disorders in children and adolescents, and methylphenidate (MPH) is a first-line stimulant drug available worldwide for its treatment. Despite the proven therapeutic efficacy, concerns have been raised regarding the possible consequences of chronic MPH exposure during childhood and adolescence. Disturbances in the neurodevelopment at these crucial stages are major concerns given the unknown future life consequences. This review is focused on the long-term adverse effects of MPH to the brain biochemistry. Reports conducted with young and/or adolescent animals and studies with humans are reviewed in the context of long-term consequences after early life-exposure. MPH pharmacokinetics is also reviewed as there are differences among laboratory animals and humans that may be relevant to extrapolate the findings. Studies reveal that exposure to MPH in laboratory animals during young and/or adolescent ages can impact the brain, but the outcomes are dependent on MPH dose, treatment period, and animal's age. Importantly, the female sex is largely overlooked in both animal and human studies. Unfortunately, human reports that evaluate adults following adolescent or child exposure to MPH are very scarce. In general, human data indicates that MPH is generally safe, although it can promote several brain changes in early ages. Even so, there is a lack of long course patient evaluation to clearly establish whether MPH-induced changes are friendly or foe to the brain and more human studies are needed to assess the adult brain changes that arise from early MPH treatment.
Language: English
Type (Professor's evaluation): Scientific
No. of pages: 14
Documents
We could not find any documents associated to the publication.
Related Publications

Of the same journal

The neurotoxicity of amphetamines during the adolescent period (2015)
Another Publication in an International Scientific Journal
Armanda Teixeira Gomes; Vera Marisa Costa; Rita Feio Azevedo; Maria de Lourdes Bastos; Felix Carvalho; Joao Paulo Capela
Effects of prenatal exposure to amphetamine in the medial prefrontal cortex of the rat (1996)
Article in International Scientific Journal
tavares, ma; silva, mc; silvaaraujo, a; xavier, mr; ali, sf
Recommend this page Top
Copyright 1996-2025 © Faculdade de Direito da Universidade do Porto  I Terms and Conditions  I Acessibility  I Index A-Z
Page created on: 2025-08-19 at 08:59:55 | Privacy Policy | Personal Data Protection Policy | Whistleblowing